Apex Biotechnology Corp. (1733.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.05B |
| Enterprise Value | 2.63B |
| P/E Ratio | 15.71 |
| PEG Ratio | 0.95 |
| Price/Sales Ratio | 1.6 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 1.28 |
| Enterprise/EBITDA | 10.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 1.94B |
| Revenue/Share | 18.58 |
| Gross Profit | 538.74M |
| EBITDA | 201.65M |
| Net Income | 163.04M |
| Diluted EPS | 1.63 |
Balance Sheet
| Total Cash | 814.85M |
| Total Cash/Share | 8.11 |
| Total Debt | 144.11M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 3.11 |
| Book Value Per Share | 18.51 |
Price History
| 52-Week Change | -15.68 |
| 52-Week High | 38.7 |
| 52-Week Low | 28 |
| Moving Average 50 Days | 31.3 |
| Moving Average 200 Days | 30.15 |
Statistics
| Average Volume | 169,796 |
| Shares Outstanding | 99.95M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.3 |
| Trailing Annual Dividend Yield | 4.36 |
| Payout Ratio | 0.63 |
| Last Split Factor | 23:20 |
| Last Split Date | July 01, 2009 |
AD
